Search research articles
Contact Us
Filters
Showing results (461-470 of 485) with videos related to
Page
of 49
Sort By:
Critical Care Medicine
|
January 8, 2014
Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle
Michele C Balas, Eduard E Vasilevskis, Keith M Olsen, et al.
American Journal of Human Genetics
|
April 25, 2000
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci
J D Rioux, M S Silverberg, M J Daly, et al.
Western Journal of Nursing Research
|
August 24, 2017
Launching Successful Beginnings for Early Career Faculty Researchers
Vicki S Conn, Cindy M Anderson, Cheryl Killion, et al.
Journal of the American College of Cardiology
|
April 8, 2026
Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
Luke J Laffin, Qiuqing Wang, Ashish Sarraju, et al.
Journal of Virology
|
February 1, 2019
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
Line K Vibholm, Julio C C Lorenzi, Joy A Pai, et al.
Gastroenterology
|
December 12, 1997
Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease
R S McLeod, B G Wolff, A H Steinhart, et al.
The Journal of Experimental Medicine
|
August 4, 2018
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117
Yehuda Z Cohen, Julio C C Lorenzi, Lisa Krassnig, et al.
The Lancet. Microbe
|
May 11, 2022
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial
Henning Gruell, Jesper D Gunst, Yehuda Z Cohen, et al.
Arthritis Research & Therapy
|
February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Plos One
|
August 9, 2019
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
Yehuda Z Cohen, Allison L Butler, Katrina Millard, et al.
Page
of 49
Search research articles
Search
Showing results (461-470 of 485) with videos related to
Sort By:
Page
of 49
Critical Care Medicine
|
January 8, 2014
Effectiveness and safety of the awakening and breathing coordination, delirium monitoring/management, and early exercise/mobility bundle
Michele C Balas, Eduard E Vasilevskis, Keith M Olsen, et al.
American Journal of Human Genetics
|
April 25, 2000
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci
J D Rioux, M S Silverberg, M J Daly, et al.
Western Journal of Nursing Research
|
August 24, 2017
Launching Successful Beginnings for Early Career Faculty Researchers
Vicki S Conn, Cindy M Anderson, Cheryl Killion, et al.
Journal of the American College of Cardiology
|
April 8, 2026
Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial
Luke J Laffin, Qiuqing Wang, Ashish Sarraju, et al.
Journal of Virology
|
February 1, 2019
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption
Line K Vibholm, Julio C C Lorenzi, Joy A Pai, et al.
Gastroenterology
|
December 12, 1997
Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease
R S McLeod, B G Wolff, A H Steinhart, et al.
The Journal of Experimental Medicine
|
August 4, 2018
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117
Yehuda Z Cohen, Julio C C Lorenzi, Lisa Krassnig, et al.
The Lancet. Microbe
|
May 11, 2022
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial
Henning Gruell, Jesper D Gunst, Yehuda Z Cohen, et al.
Arthritis Research & Therapy
|
February 20, 2024
Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network
Peter M Izmirly, Mimi Y Kim, Philip M Carlucci, et al.
Plos One
|
August 9, 2019
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study
Yehuda Z Cohen, Allison L Butler, Katrina Millard, et al.
Page
of 49